Physician profile
Jason A Liauw
NPI 1285806091
$590,202.38
in general payments reported to CMS, 2019-2025
62 companies · $121K in 2025
The $121K reported for 2025 was more than what 98% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $118K · 2020: $55K · 2021: $40K · 2022: $86K · 2023: $72K · 2024: $98K · 2025: $121K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $209K · Consulting Fee: $44K · Food and Beverage: $20K · Travel and Lodging: $17K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $209,219.10 |
| Consulting Fee | $44,104.87 |
| Food and Beverage | $20,276.29 |
| Travel and Lodging | $17,009.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $158,639.11 | 2019-2023 | Reline, Alif, Xlif |
| Globus Medical, INC. | $147,537.35 | 2019-2025 | Reline, Creo S2ai, Creo |
| Spineart Sa | $128,737.33 | 2022-2025 | Perla Tl - Mis |
| Spineart USA INC | $100,297.77 | 2019-2025 | Perla Tl, Perla Tl, Baguera C |
| Neo Spine USA, INC. | $11,394.58 | 2022-2025 | Neo Pedicle Screw System |
| Biogennix, LLC | $9,391.48 | 2019-2025 | Agilon, Directcell |
| Medtronic, INC. | $8,752.49 | 2021-2025 | Intellis Adaptivestim, Stealthstation S8 Platform, Inceptiv |
| Kuros Biosciences USA, INC | $8,627.10 | 2025 | Magnetos |
| Stryker Corporation | $2,248.33 | 2019-2023 | Everest Spinal System, N/A |
| Carlsmed, INC. | $2,022.47 | 2024-2025 | Aprevo |
| Integrity Implants INC. Dba Accelus | $1,591.28 | 2023 | |
| Precision Spine, INC. | $1,500.00 | 2019 | |
| Orthofix Medical, INC. | $1,131.77 | 2022-2024 | Northstar, Mariner Deformity, Lattus |
| Saxum Surgical, INC. | $885.42 | 2024 | |
| Alphatec Spine, INC | $855.61 | 2021-2023 | Identiti, Battalion Tlif - PC, Lif |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $817.72 | 2023-2025 | |
| Djo, LLC | $744.55 | 2022 | |
| Abbott Laboratories | $603.72 | 2019-2025 | Proclaim, Eterna, Infinity |
| Boston Scientific Corporation | $529.50 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Kyocera Medical Technologies, INC. | $505.19 | 2023-2024 | |
| Saluda Medical Americas, INC. | $318.22 | 2024-2025 | Evoke |
| Medtronic USA, INC. | $259.71 | 2019-2020 | |
| Intrinsic Therapeutics | $237.43 | 2025 | Barricaid Acd (Annular Closure Device) |
| Nevro Corp. | $234.39 | 2019-2023 | Senza |
| Amplify Surgical, INC. | $189.61 | 2020-2022 | |
| Baxter Healthcare | $176.09 | 2019-2024 | Floseal |
| Arthrex, INC. | $154.00 | 2024 | |
| Spineology INC. | $151.11 | 2019-2025 | Optimesh Expandable Interbody Fusion System |
| Biotronik Nro, INC. | $122.59 | 2024-2025 | Prospera |
| Bioventus LLC | $119.87 | 2023-2025 | Sonastar, Bonescalpel, Bonescalpel & Sonicone (O.R.) |
| Si-Bone, INC. | $114.66 | 2021-2025 | |
| 7d Surgical INC. | $105.71 | 2019 | |
| Zimmer Biomet Holdings, INC. | $93.90 | 2019-2021 | |
| Integrity Implants INC. | $88.60 | 2022 | Flarehawk |
| Depuy Synthes Sales INC. | $86.12 | 2019-2021 | |
| Abbvie INC. | $75.33 | 2023-2025 | |
| Icotec Medical INC. | $70.25 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Vader Pedicle System, Rod, Carbon/Peek, Curved, 6.0 R450 X 200 Mm |
| Augmedics INC. | $69.38 | 2023-2025 | Xvision |
| Biedermann Motech, INC. | $57.11 | 2021 | |
| Innovasis INC | $56.47 | 2022 | |
| Xoran Technologies LLC | $56.00 | 2022 | |
| Integra Lifesciences Corporation | $54.98 | 2021-2022 | |
| Titan Spine, LLC | $52.68 | 2019 | |
| Ethicon US, LLC | $47.64 | 2021 | |
| Davol INC. | $47.55 | 2024 | Avitene Ultrafoam |
| Zimvie INC. | $47.13 | 2022 | |
| Life Spine, INC. | $34.79 | 2022 | |
| Analogic Corporation | $25.68 | 2019 | |
| Amgen INC. | $24.60 | 2019 | |
| Averitas Pharma INC. | $23.62 | 2024 | Qutenza |
| Merck Sharp & Dohme LLC | $23.40 | 2022 | |
| Biotronik INC. | $22.98 | 2020 | |
| Xtant Medical INC | $21.90 | 2025 | |
| Centinel Spine, LLC | $20.07 | 2024 | Prodisc L |
| Spinal Simplicity, LLC | $17.47 | 2022 | |
| Arteriocyte Medical Systems, INC. | $17.33 | 2024 | Magellan |
| Kls-Martin L.P. | $16.48 | 2021 | |
| Smith+Nephew, INC. | $15.02 | 2022 | |
| Lemaitre Vascular, INC. | $14.58 | 2021 | |
| Seaspine Orthopedics Corporation | $13.76 | 2019 | |
| Ossdsign USA Incorporated | $11.40 | 2025 | Ossdsign Catalyst |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$16,500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Liauw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.